Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Francesco Diciolla is active.

Publication


Featured researches published by Francesco Diciolla.


The Journal of Thoracic and Cardiovascular Surgery | 1999

Axillary artery cannulation in type a aortic dissection operations

Eugenio Neri; Massimo Massetti; Gianni Capannini; Enrico Carone; Enrico Tucci; Francesco Diciolla; Edvin Prifti; Carlo Sassi

BACKGROUND Femoral arteries are the preferred site of peripheral cannulation for arterial inflow in type A aortic dissection operations. The presence of aortoiliac aneurysms, severe peripheral occlusive disease, atherosclerosis of the femoral vessels, and distal extension of the aortic dissection may preclude their utilization. Axillary artery cannulation may represent a valid alternative in these circumstances. METHODS Between January 15, 1989, and August 20, 1998, in our institution, 22 of 152 operations (14.4%) for acute type A aortic dissection were performed with the use of the axillary artery for the arterial inflow. Axillary artery cannulation was undertaken in the presence of femoral arteries bilaterally compromised by dissection in 12 patients (54.5%), abdominal aorta and peripheral aneurysm in 5 patients (22.7%), severe atherosclerosis of both femoral arteries in 3 patients (13. 6%), and aortoiliac occlusive disease in 2 patients (9.1%). In all patients, distal anastomosis was performed with an open technique after deep hypothermic circulatory arrest. Retrograde cerebral perfusion was used in 9 patients (40.9%). RESULTS Axillary artery cannulation was successful in all patients. The left axillary artery was cannulated in 20 patients (90.9%), and the right axillary artery was cannulated in 2 patients (9.1%). Axillary artery cannulation followed an attempt of femoral artery cannulation in 15 patients (68. 2%). All patients survived the operation, and no patient had a cerebrovascular accident. No axillary artery thrombosis, no brachial plexus injury, and no intraoperative malperfusion were recorded in this series. Two patients (9.1%) died in the hospital of complications not related to axillary artery cannulation. CONCLUSIONS In patients with type A aortic dissection in whom femoral arteries are acutely or chronically diseased, axillary artery cannulation represents a safe and effective means of providing arterial inflow during cardiopulmonary bypass.


The FASEB Journal | 2002

Changes of peripheral A2A adenosine receptors in chronic heart failure and cardiac transplantation

Katia Varani; Franco Laghi-Pasini; Alessandra Camurri; Pier Leopoldo Capecchi; Massimo Maccherini; Francesco Diciolla; L. Ceccatelli; Pietro Enea Lazzerini; Canan Ulouglu; Flaminio Cattabeni; Pier Andrea Borea; Maria P. Abbracchio

Peripheral blood mononuclear cells of chronic heart failure (CHF) patients produce great amounts of pro‐inflammatory cytokines, indicating that circulating cells are activated and could mirror changes occurring in inflammatory cells infiltrating the failing heart. Adenosine is a regulatory metabolite acting through four membrane receptors that are linked to adenylyl cyclase: activation of the A2A receptor subtype has been reported to inhibit cytokine release. Changes of the adenosinergic system may play a role in CHF development. Here we report an increase of A2A receptor expression, density, and coupling to adenylyl cyclase in blood circulating cells of CHF patients. A2A receptor up‐regulation was also found in the explanted hearts of these patients, suggesting that changes of peripheral adenosine receptors mirror changes occurring in the disease target organ. In a cohort of patients followed longitudinally after heart transplantation, alterations of peripheral A2A adenosine receptor progressively normalized to control values within 6 months, suggesting that improvement of cardiac performance is accompanied by progressive restoration of a normal adenosinergic system. These results validate the importance of the A2A receptor in human diseases characterized by a marked inflammatory/immune component and suggest that the evaluation of this receptor in peripheral blood cells may be useful for monitoring hemodynamic changes and the efficacy of pharmacological and non‐pharmacological treatments in CHF patients.


The Annals of Thoracic Surgery | 1999

Evolution toward dissection of an intramural hematoma of the ascending aorta

Eugenio Neri; Gianni Capannini; Enrico Carone; Francesco Diciolla; Carlo Sassi

Intramural hematoma of the aorta is a condition increasingly observed in clinical practice. Uncertainty exists whether such lesions represent a different pathology or simply the precursors of classic dissecting aneurysm. The patient was a 76-year-old woman with intramural hematoma of the ascending aorta. Clinical course, progression of the lesion to type A aortic dissection, and surgical treatment are described. Although natural history of intramural hematoma of the ascending aorta is not clearly elucidated, the case presented confirms that the evolution toward intimal flap formation is possible and that we cannot foresee the stabilization of these lesions. We stress that intramural hematoma of the ascending aorta has to be managed as an aortic type A dissection and that aggressive treatment is advisable.


Acute Cardiac Care | 2009

Cardiogenic shock complicating myocardial infarction in a doped athlete

Stefano Lunghetti; Zacà; Silvia Maffei; Arcangelo Carrera; Rosaria Gaddi; Francesco Diciolla; Massimo Maccherini; Mario Chiavarelli; Sergio Mondillo; Roberto Favilli

Abuse of doping agents may pose a higher risk for heart disease including acute myocardial infarction. We report the case of a 50-year-old body-builder Caucasian man with a long-standing abuse of nandrolone and erythropoietin that developed a ventricular septal defect following acute myocardial infarction. This mechanical complication led to cardiogenic shock ultimately treated with the implantation of a circulatory support by means of extracorporeal membrane oxygenation. The patient subsequently underwent orthotopic heart transplantation. The association of intense isometric exercise, abuse of erythropoietin and nandrolone is likely to have predisposed to coronary thrombus formation and acute myocardial infarction, as the patient presented no traditional cardiovascular risk factors.


TRANSPLANTATION PROCEEDINGS | 2017

First World Report of Internal Power Cable Repair in Left Ventricular Assist Device Jarvik 2000: Case Report

Carlo Sassi; Matteo Cameli; Aleksander Dokollari; Francesco Diciolla; Sabino Scolletta; Carmelo Ricci; Pierleone Lucatelli; Sergio Mondillo; Massimo Maccherini

BACKGROUND There are limited clinical reports concerning internal power cable fixing in left ventricular assist device (L-VAD) patients. Actually there are no reports in the literature about Jarvik 2000 internal cable repair. We show the first description of a technique for surgical reparation of such a fatal complication. PATIENT HISTORY The patient was a 62-year-old woman who had L-VAD implantation (Jarvik 2000) with outflow graft apposition in descending thoracic aorta through left thoracotomy access, in 2009. She arrived urgently on January 25, 2014 for Jarvik 2000 dysfunction correlated with head movements. The neck X-rays revealed the rupture of one of the nine power cables located inside the neck and the damaging of two more cables nearby to be ruptured. On the same day she got pump failure due to the final interruption of the remaining two cables, we were obliged to install femoro-femoral extracorporeal membrane oxygenation (ECMO) assistance, to repair the power cables, approaching them through a pacemaker extension cable. The L-VAD outflow was occluded with vascular ball occluder inserted via right axillary artery under fluoroscopy before ECMO installation. At the end the ECMO assistance was interrupted and the Jarvik 2000 was turned back on. The patient was dismissed from the hospital 12 days after the procedure. DISCUSSION At the moment the international literature is poor regarding this issue. This case provides evidence that in emergency conditions ECMO assistance is mandatory and a hybrid surgical and radiological approach could help to repair the damage in safe conditions.


Journal of Receptors and Signal Transduction | 2017

Adenosine receptors expression in cardiac fibroblasts of patients with left ventricular dysfunction due to valvular disease

Silvia Del Ry; Manuela Cabiati; Veronica Della Latta; Stefania Zimbone; Mariarita Natale; Pietro Enea Lazzerini; Francesco Diciolla; Pier Leopoldo Capecchi; Franco Laghi-Pasini; Maria Aurora Morales

Abstract Context: Adenosine restores tissue homeostasis through the interaction with its membrane receptors (AR) expressed on fibroblasts, endothelial cells, smooth muscle cells and leukocytes, but their modulation is still not fully understood. Objective: To evaluate whether changes in the transcriptomic profiling of adenosine receptors (AR) occur in cardiac fibroblasts (CF) of patients (pts) with LV dysfunction due to valvular disease (V). The secondary aim was to compare in the same pts the results obtained at cardiac level with those found in circulating leukocytes. Materials and methods: Auricle fragments were excised from 13 pts during prosthetic implantation while blood samples were collected from pts (n = 9) and from healthy subjects (C, n = 7). In 7 pts cardiac biopsy and blood samples were taken simultaneously. A human CF atrial cell line (cc) was used as control. Results: AR higher levels of mRNA expression were observed with real-time PCR in Vpts compared to C, both at cardiac (overexpression A1R:98%, A2AR:63%, A2BR:87%, A3R:85%, CD39:92%, CD73:93%) and at peripheral level (A1R vs C: p = .0056; A2AR vs C: p = .0173; A2BR vs C: p = .0272; A3R vs C: p = .855; CD39 vs C: p = .0001; CD73 vs C: p = .0091). Conclusion: All AR subtypes were overexpressed in CF of Vpts. The same trends in AR expression at cardiac level was assessed on circulating leukocytes, thus opening a new road to minimally invasive studies of the adenosinergic system in cardiac patients.


Human Pathology | 2001

Smooth muscle cells of the media in the dilatative pathology of ascending thoracic aorta: Morphology, immunoreactivity for osteopontin, matrix metalloproteinases, and their inhibitors

Vaiva Lesauskaite; Piero Tanganelli; Carlo Sassi; Eugenio Neri; Francesco Diciolla; Laima Ivanoviene; Maria Carmela Epistolato; Anna Vittoria Lalinga; Carlo Alessandrini; Donatella Spina


Journal of Molecular and Cellular Cardiology | 2001

The Properties of the Pacemaker Current IFin Human Ventricular Myocytes are Modulated by Cardiac Disease

Elisabetta Cerbai; Laura Sartiani; Petra DePaoli; Roberto Pino; Massimo Maccherini; Federico Bizzarri; Francesco Diciolla; Giuseppe Davoli; Guido Sani; Alessandro Mugelli


Journal of Vascular Surgery | 2000

Localized dissection and delayed rupture of the abdominal aorta after extracorporeal shock wave lithotripsy

Eugenio Neri; Gianni Capannini; Francesco Diciolla; Enrico Carone; Alberto Tripodi; Enrico Tucci; Carlo Sassi


Medicine and Science in Sports and Exercise | 2003

Serial assessment of peak VO2 and VO2 kinetics early after heart transplantation

Emma Borrelli; Silvia Pogliaghi; Alessandro Molinello; Francesco Diciolla; Massimo Maccherini; Bruno Grassi

Collaboration


Dive into the Francesco Diciolla's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Guido Sani

University of Florence

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge